- Home
- MAG vs OGN Comparison
MAG vs OGN Comparison
Compare MAG & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAG
- OGN
- Stock Information
- Founded
- MAG N/A
- OGN 1923
- Country
- MAG Canada
- OGN United States
- Employees
- MAG N/A
- OGN N/A
- Industry
- MAG Precious Metals
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- MAG Basic Materials
- OGN Health Care
- Exchange
- MAG Nasdaq
- OGN Nasdaq
- Market Cap
- MAG 2.2B
- OGN 2.5B
- IPO Year
- MAG N/A
- OGN N/A
- Fundamental
- Price
- MAG $20.91
- OGN $9.75
- Analyst Decision
- MAG Buy
- OGN Hold
- Analyst Count
- MAG 3
- OGN 4
- Target Price
- MAG $18.83
- OGN $18.00
- AVG Volume (30 Days)
- MAG 2.2M
- OGN 4.1M
- Earning Date
- MAG 08-01-2025
- OGN 08-05-2025
- Dividend Yield
- MAG 1.93%
- OGN 0.81%
- EPS Growth
- MAG 57.48
- OGN N/A
- EPS
- MAG 0.88
- OGN 2.88
- Revenue
- MAG N/A
- OGN $6,294,000,000.00
- Revenue This Year
- MAG N/A
- OGN N/A
- Revenue Next Year
- MAG N/A
- OGN $1.11
- P/E Ratio
- MAG $23.55
- OGN $3.43
- Revenue Growth
- MAG N/A
- OGN N/A
- 52 Week Low
- MAG $11.29
- OGN $8.01
- 52 Week High
- MAG $21.83
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- MAG 68.85
- OGN 53.19
- Support Level
- MAG $20.70
- OGN $9.73
- Resistance Level
- MAG $21.69
- OGN $10.30
- Average True Range (ATR)
- MAG 0.45
- OGN 0.35
- MACD
- MAG -0.15
- OGN 0.06
- Stochastic Oscillator
- MAG 71.68
- OGN 64.98
About MAG MAG Silver Corporation
MAG Silver Corp is a Canadian mining company. It is focused on advancing high-grade, district-scale precious metals projects in the Americas. The Company's principal asset is in the Juanicipio Mine located in Zacatecas, Mexico, which produced around 4,000 tonnes per day commercially. The company is also Interested in the Larder project. Its operations are Juanicipio, Deer Trail, and Larder. The Juanicipio Mine recognizes silver, gold, lead, and zinc revenue from concentrate sales.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.